Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

Stefan Halbherr; Stefanie Lerch; Sebastian Bellwald; Petra Polakova; Bettina Bannert; Marie Roumet; Roch-Philippe Charles; Martin A. Walter; Corrado Bernasconi; Camille Peitsch; Pascal C. Baumgartner; Céline Kaufmann; Heinrich P. Mattle; Alain Kaelin-Lang; Andreas Hartmann; Michael Schuepbach

doi:10.1101/2024.09.05.24313105

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, Petra Polakova, Bettina Bannert, Marie Roumet, Roch-Philippe Charles, View ORCID ProfileMartin A. Walter, View ORCID ProfileCorrado Bernasconi, Camille Peitsch, View ORCID ProfilePascal C. Baumgartner, Céline Kaufmann, Heinrich P. Mattle, View ORCID ProfileAlain Kaelin-Lang, View ORCID ProfileAndreas Hartmann, View ORCID ProfileMichael Schuepbach

doi: https://doi.org/10.1101/2024.09.05.24313105

Stefan Halbherr

1InnoMedica Schweiz AG, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stefanie Lerch

1InnoMedica Schweiz AG, Switzerland

2Skin and Soft Tissue Research Center, University Children’s Hospital Zurich, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sebastian Bellwald

3Institute of Neurology, Konolfingen, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Petra Polakova

1InnoMedica Schweiz AG, Switzerland

4Swiss pediatric oncology group, Bern, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Bettina Bannert

5Department of Clinical Research, University of Basel, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marie Roumet

6Department of Clinical Research, University of Bern, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Roch-Philippe Charles

1InnoMedica Schweiz AG, Switzerland

7Swiss Group for Clinical Cancer Research, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Martin A. Walter

8St. Anna Hospital, University of Lucerne, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Martin A. Walter

Corrado Bernasconi

9Limites Medical Research Ltd., Vacallo, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Corrado Bernasconi

Camille Peitsch

1InnoMedica Schweiz AG, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Pascal C. Baumgartner

1InnoMedica Schweiz AG, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pascal C. Baumgartner

Céline Kaufmann

1InnoMedica Schweiz AG, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Heinrich P. Mattle

10University of Bern, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alain Kaelin-Lang

11Ente Ospedaliero Cantonale, Lugano Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Alain Kaelin-Lang

Andreas Hartmann

12Assistance-Publique Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, Département de Neurologie, Paris, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Andreas Hartmann

Michael Schuepbach

3Institute of Neurology, Konolfingen, Switzerland

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michael Schuepbach
For correspondence: nik@hin.ch

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Article usage

Article usage: September 2024 to December 2024

	Abstract	Full	Pdf
Sep 2024	337	35	88
Oct 2024	58	10	22
Nov 2024	64	9	59
Dec 2024	11	4	9

View the discussion thread.

PreviousNext

Posted September 06, 2024.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

Stefan Halbherr, Stefanie Lerch, Sebastian Bellwald, Petra Polakova, Bettina Bannert, Marie Roumet, Roch-Philippe Charles, Martin A. Walter, Corrado Bernasconi, Camille Peitsch, Pascal C. Baumgartner, Céline Kaufmann, Heinrich P. Mattle, Alain Kaelin-Lang, Andreas Hartmann, Michael Schuepbach

medRxiv 2024.09.05.24313105; doi: https://doi.org/10.1101/2024.09.05.24313105

Share This Article:

Citation Tools

Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single center open-label clinical phase I trial (NEON trial)

medRxiv 2024.09.05.24313105; doi: https://doi.org/10.1101/2024.09.05.24313105

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Neurology

Subject Areas

All Articles

Addiction Medicine (398)
Allergy and Immunology (708)
Anesthesia (200)
Cardiovascular Medicine (2911)
Dentistry and Oral Medicine (332)
Dermatology (249)
Emergency Medicine (438)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1030)
Epidemiology (12693)
Forensic Medicine (10)
Gastroenterology (825)
Genetic and Genomic Medicine (4554)
Geriatric Medicine (413)
Health Economics (724)
Health Informatics (2903)
Health Policy (1067)
Health Systems and Quality Improvement (1070)
Hematology (384)
HIV/AIDS (920)
Infectious Diseases (except HIV/AIDS) (14071)
Intensive Care and Critical Care Medicine (842)
Medical Education (422)
Medical Ethics (115)
Nephrology (466)
Neurology (4321)
Nursing (233)
Nutrition (634)
Obstetrics and Gynecology (798)
Occupational and Environmental Health (733)
Oncology (2255)
Ophthalmology (642)
Orthopedics (258)
Otolaryngology (324)
Pain Medicine (277)
Palliative Medicine (83)
Pathology (496)
Pediatrics (1194)
Pharmacology and Therapeutics (502)
Primary Care Research (493)
Psychiatry and Clinical Psychology (3724)
Public and Global Health (6903)
Radiology and Imaging (1521)
Rehabilitation Medicine and Physical Therapy (892)
Respiratory Medicine (914)
Rheumatology (435)
Sexual and Reproductive Health (442)
Sports Medicine (381)
Surgery (483)
Toxicology (60)
Transplantation (209)
Urology (178)